JP2023545730A5 - - Google Patents
Info
- Publication number
- JP2023545730A5 JP2023545730A5 JP2023521335A JP2023521335A JP2023545730A5 JP 2023545730 A5 JP2023545730 A5 JP 2023545730A5 JP 2023521335 A JP2023521335 A JP 2023521335A JP 2023521335 A JP2023521335 A JP 2023521335A JP 2023545730 A5 JP2023545730 A5 JP 2023545730A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088787P | 2020-10-07 | 2020-10-07 | |
| US63/088,787 | 2020-10-07 | ||
| US202063123337P | 2020-12-09 | 2020-12-09 | |
| US63/123,337 | 2020-12-09 | ||
| PCT/US2021/071762 WO2022077010A1 (en) | 2020-10-07 | 2021-10-07 | Stat degraders and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545730A JP2023545730A (ja) | 2023-10-31 |
| JPWO2022077010A5 JPWO2022077010A5 (https=) | 2024-10-15 |
| JP2023545730A5 true JP2023545730A5 (https=) | 2024-10-15 |
Family
ID=81126142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521335A Pending JP2023545730A (ja) | 2020-10-07 | 2021-10-07 | Ｓｔａｔ分解剤およびそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240293423A1 (https=) |
| EP (1) | EP4225303A4 (https=) |
| JP (1) | JP2023545730A (https=) |
| AU (1) | AU2021358130A1 (https=) |
| CA (1) | CA3194492A1 (https=) |
| IL (1) | IL301830A (https=) |
| MX (1) | MX2023003973A (https=) |
| WO (1) | WO2022077010A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI875749B (zh) | 2019-04-05 | 2025-03-11 | 美商凱麥拉醫療公司 | Stat降解劑及其用途 |
| CN115677831B (zh) * | 2021-07-22 | 2026-03-17 | 杭州和正医药有限公司 | 拟肽类stat降解药物、组合物及应用 |
| EP4499656A1 (en) * | 2022-03-31 | 2025-02-05 | Recludix Pharma, Inc. | Stat modulators and uses thereof |
| WO2024064080A1 (en) * | 2022-09-19 | 2024-03-28 | Kymera Therapeutics, Inc. | Stat6 degraders and uses thereof |
| EP4709370A2 (en) * | 2023-05-09 | 2026-03-18 | Recludix Pharma, Inc. | Stat degraders and uses thereof |
| EP4712974A2 (en) * | 2023-05-15 | 2026-03-25 | Recludix Pharma, Inc. | Stat degraders and uses thereof |
| AU2024334386A1 (en) * | 2023-08-30 | 2026-02-19 | Kymera Therapeutics, Inc. | Stat6 degraders and uses thereof |
| WO2025217647A1 (en) * | 2024-04-12 | 2025-10-16 | Kymera Therapeutics, Inc. | Stat6 degraders and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010077589A2 (en) * | 2008-12-08 | 2010-07-08 | The Regents Of The University Of Michigan Office Of Technology Transfer | Stat3 inhibitors and therapeutic methods using the same |
| MX2020003190A (es) * | 2017-09-22 | 2020-11-11 | Kymera Therapeutics Inc | Degradadores de proteinas y usos de los mismos. |
| CN114269763A (zh) * | 2019-03-26 | 2022-04-01 | 美国密歇根州立大学试剂中心 | Stat3的小分子降解剂 |
-
2021
- 2021-10-07 JP JP2023521335A patent/JP2023545730A/ja active Pending
- 2021-10-07 IL IL301830A patent/IL301830A/en unknown
- 2021-10-07 AU AU2021358130A patent/AU2021358130A1/en not_active Abandoned
- 2021-10-07 MX MX2023003973A patent/MX2023003973A/es unknown
- 2021-10-07 CA CA3194492A patent/CA3194492A1/en active Pending
- 2021-10-07 WO PCT/US2021/071762 patent/WO2022077010A1/en not_active Ceased
- 2021-10-07 EP EP21878728.1A patent/EP4225303A4/en not_active Withdrawn
- 2021-10-07 US US18/030,865 patent/US20240293423A1/en active Pending